Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model

Experimental Lung Research

Volumn 30, Issue 4, 2004, Pages 251-260

  Lachmann, R A ^a   Van Kaam, A H L C ^b   Haitsma, J J ^a   Verbrugge, S J C ^a   Delreu, F ^a   Lachmann, B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Bronchoalveolar lavage; CFUs; Klebsiella pneumoniae; Pentaglobin; Rat

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL PNEUMONIA; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENTEROBACTER INFECTION; KLEBSIELLA PNEUMONIAE; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RESPIRATORY DISTRESS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, BACTERIAL; BACTEREMIA; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BRONCHOALVEOLAR LAVAGE; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; IMMUNE SERA; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 2642544051     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490439013     Document Type: Article

References (24)

1. Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, Gibert C: Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;157:1165-1172.
2. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985;132:485-489.
3. Verbrugge SJ, Sorm V, van't Veen A, Mouton JW, Gommers D, Lachmann B: Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation. Intensive Care Med. 1998;24:172-177.
4. Nahum A, Hoyt J, Schmitz L, Moody J, Shapiro R, Marini JJ: Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. Crit Care Med. 1997;25:1733-1743.
5. Lin CY ZH, Porro G, Cheng KC, Slutsky AS: High volume, zero PEEP mechanical ventilation may increase susceptibility to bacteremia. Am J Respir Crit Care Med. 2001;163:A802.
6. Haitsma JJ, Uhlig S, Goggel R, Verbrugge SJ, Lachmann U, Lachmann B: Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med. 2000;26:1515-1522.
7. Ranieri VM, Giunta F, Suter PM, Slutsky AS: Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284:43-44.
8. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282:54-61.
9. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274:639-644.
10. Bauer TT, Ferrer R, Angrill J, Schultze-Werninghaus G, Torres A: Ventilator-associated pneumonia: incidence, risk factors, and microbiology. Semin Respir Infect. 2000;15:272-279.
11. Lissner R, Struff WG, Autenrieth IB, Woodcock BG, Karch H: Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl. 1999;584:17-25.
12. Garbett ND, Munro CS, Cole PJ: Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin. Clin Exp Immunol. 1989;76:8-12.
13. Norrby-Teglund A, Ihendyane N, Kansal R, Basma H, Kotb M, Andersson J, Hammarstrom L: Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens. Clin Infect Dis. 2000;31:1175-1182.
14. Lachmann B, Robertson B, Vogel J: In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand. 1980;24:231-236.
15. Mead J, Takishima T, Leith D: Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol. 1970;28:596-608.
16. Verbrugge SJ, Lachmann B: Mechanisms of ventilation-induced lung injury: physiological rationale to prevent it. Monaldi Arch Chest Dis. 1999;54:22-37.
17. Johanson WG, Jr., Higuchi JH, Woods DE, Gomez P, Coalson JJ: Dissemination of Pseudomonas aeruginosa during lung infection in hamsters. Role of oxygen-induced lung injury. Am Rev Respir Dis. 1985;132:358-361.
18. Seidenfeld JJ, Mullins RC 3rd, Fowler SR, Johanson WG Jr: Bacterial infection and acute lung injury in hamsters. Am Rev Respir Dis. 1986;134:22-26.
19. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR: Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood. 1999;93:942-951.
20. Alejandria MM, Lansang MA, Dans LF, Mantaring JB: Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev. 2002;CD001090.
21. Dominioni L, Dionigi R, Zanello M, Chiaranda M, Acquarolo A, Ballabio A, Sguotti C: Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. Arch Surg. 1991;126:236-240.
22. Dominioni L, Bianchi V, Imperatori A, Dionigi R: The use of IVIG in patients at high risk of bacterial infections. In: Proceedings of the 4th Interlaken's Meeting of IVIG. England. Parthenon; 1996:209-213.
23. Tugrul S, Ozcan PE, Akinci O, Seyhun Y, Cagatay A, Cakar N, Esen F: The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]. Crit Care. 2002;6:357-362.
24. Nydegger UE: Sepsis and polyspecific intravenous immunoglobulins. J Clin Apheresis. 1997;12:93-99.